These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8223768)

  • 1. The influence of image resolution on the positron emission tomographic measurement of caudate glucose consumption.
    Kuwert T; Sures T; Herzog H; Jansen P; Langen KJ; Loken M; Hennerici M; Feinendegen LE
    Eur J Nucl Med; 1993 Sep; 20(9):753-8. PubMed ID: 8223768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of size of regions of interest on PET evaluation of caudate glucose consumption.
    Kuwert T; Ganslandt T; Jansen P; Jülicher F; Lange H; Herzog H; Scholz D; Aulich A; Feinendegen LE
    J Comput Assist Tomogr; 1992; 16(5):789-94. PubMed ID: 1387888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of Huntington's disease.
    Kuwert T; Noth J; Scholz D; Schwarz M; Lange HW; Töpper R; Herzog H; Aulich A; Feinendegen LE
    Mov Disord; 1993; 8(1):98-106. PubMed ID: 8419813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional cerebral glucose consumption measured by positron emission tomography in patients with Wilson's disease.
    Kuwert T; Hefter H; Scholz D; Milz M; Weiss P; Arendt G; Herzog H; Loken M; Hennerici M; Feinendegen LE
    Eur J Nucl Med; 1992; 19(2):96-101. PubMed ID: 1563446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose metabolism in the caudate nuclei of patients with eating disorders, measured by PET.
    Krieg JC; Holthoff V; Schreiber W; Pirke KM; Herholz K
    Eur Arch Psychiatry Clin Neurosci; 1991; 240(6):331-3. PubMed ID: 1831664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional cerebral glucose metabolism in healthy volunteers determined by fluordeoxyglucose positron emission tomography: appearance and variance in the transaxial, coronal, and sagittal planes.
    Ivançević V; Alavi A; Souder E; Mozley PD; Gur RE; Bénard F; Munz DL
    Clin Nucl Med; 2000 Aug; 25(8):596-602. PubMed ID: 10944013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional caudate imaging in symptomatic Huntington's disease: positron emission tomography versus single-photon emission computed tomography.
    Martin WR; Hoskinson M; Kremer B; Maguire C; McEwan A
    J Neuroimaging; 1995 Oct; 5(4):227-32. PubMed ID: 7579751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal caudate glucose metabolism in persons at risk for Huntington's disease.
    Young AB; Penney JB; Starosta-Rubinstein S; Markel D; Berent S; Rothley J; Betley A; Hichwa R
    Arch Neurol; 1987 Mar; 44(3):254-7. PubMed ID: 2950844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
    Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL
    Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder.
    Schwartz JM; Stoessel PW; Baxter LR; Martin KM; Phelps ME
    Arch Gen Psychiatry; 1996 Feb; 53(2):109-13. PubMed ID: 8629886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered frontostriatal relationship in unmedicated schizophrenic patients.
    Biver F; Goldman S; Luxen A; Delvenne V; De Maertelaer V; De La Fuente J; Mendlewicz J; Lotstra F
    Psychiatry Res; 1995 Sep; 61(3):161-71. PubMed ID: 8545500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography.
    Eidelberg D; Dhawan V; Moeller JR; Sidtis JJ; Ginos JZ; Strother SC; Cederbaum J; Greene P; Fahn S; Powers JM
    J Neurol Neurosurg Psychiatry; 1991 Oct; 54(10):856-62. PubMed ID: 1744638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease.
    Kuwert T; Lange HW; Langen KJ; Herzog H; Aulich A; Feinendegen LE
    Brain; 1990 Oct; 113 ( Pt 5)():1405-23. PubMed ID: 2147116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography in the early diagnosis of Huntington's disease.
    Hayden MR; Martin WR; Stoessl AJ; Clark C; Hollenberg S; Adam MJ; Ammann W; Harrop R; Rogers J; Ruth T
    Neurology; 1986 Jul; 36(7):888-94. PubMed ID: 2940474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral metabolism of glucose in benign hereditary chorea.
    Suchowersky O; Hayden MR; Martin WR; Stoessl AJ; Hildebrand AM; Pate BD
    Mov Disord; 1986; 1(1):33-44. PubMed ID: 2973557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic recovery in caudate nucleus of children following cerebral hemispherectomy.
    Chugani HT; Jacobs B
    Ann Neurol; 1994 Nov; 36(5):794-7. PubMed ID: 7979226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of iterative reconstruction, attenuation correction, and image fusion in the interpretation of FDG PET images with an integrated dual-head coincidence camera and X-ray-based attenuation maps.
    Delbeke D; Martin WH; Patton JA; Sandler MP
    Radiology; 2001 Jan; 218(1):163-71. PubMed ID: 11152796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18.
    Baxter LR; Phelps ME; Mazziotta JC; Schwartz JM; Gerner RH; Selin CE; Sumida RM
    Arch Gen Psychiatry; 1985 May; 42(5):441-7. PubMed ID: 3872649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan.
    Kuhl DE; Phelps ME; Markham CH; Metter EJ; Riege WH; Winter J
    Ann Neurol; 1982 Nov; 12(5):425-34. PubMed ID: 6217782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial metabolic imaging by means of fluorine-18 deoxyglucose/technetium-99m sestamibi dual-isotope single-photon emission tomography.
    Stoll HP; Hellwig N; Alexander C; Ozbek C; Schieffer H; Oberhausen E
    Eur J Nucl Med; 1994 Oct; 21(10):1085-93. PubMed ID: 7828618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.